Misonix is now part of Bioventus and provides state-of-the-art, minimally invasive ultrasonic medical devices and regenerative tissue products used in spine, neurosurgery, orthopaedics, and wound care to enhance clinical outcomes.
Cure Surgicals partners with Misonix to bring cutting-edge ultrasonic surgical technologies and associated regenerative solutions to surgeons and hospitals in the region.
Through this collaboration, healthcare providers gain access to platforms such as BoneScalpel and SonaStar that are designed to improve surgical precision, reduce trauma to surrounding tissue, and support better patient outcomes.
Partnership Overview
Cure Surgicals collaborates with DePuy Synthes to make advanced orthopaedic and neurosurgical solutions accessible to healthcare providers in the region.
Through this partnership, clinicians gain access to clinically proven implants, instruments, and data-enabled solutions designed to support predictable outcomes, efficient workflows, and long-term patient function.
Shared Values & Goals
- Focus on innovative, evidence-based technologies that enable safer, more precise and minimally invasive surgery.
- Shared commitment to improving healing, recovery times, and overall patient quality of life.
- Alignment on supporting surgeons with reliable, high-performance systems and strong clinical education.
- Dedication to ethical practices and long-term partnerships that advance standards of care in spine, neuro and orthopaedic surgery.
